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Summary
Total blood protein measured in calves
between 1 and 7 days of age is a good indica-
tor of the sufficiency of colostral intake and
level of immunity passed to the calf.  This
measurement can be used to improve calf
management strategies and thereby calf
performance.  Total blood protein concentra-
tions are associated with immunoglobulin
absorption in the neonatal calf, which can
impact calf morbidity and mortality.  Blood
protein >5.5 g/dl indicates sufficient immu-
noglobulin absorption, and blood protein
<5.0 g/dl indicates insufficient absorption.
Insufficient immunoglobulin absorption
increases the risk of calf morbidity and
mortality.  The dry cow health program,
proper collection, and management of
colostrum help ensure that quality colostrum
is available for the newborn calf.  Proper
colostrum administration and low-stress calf
management also ensure maximal immuno-
globulin absorption. Timing of colostral
intake affects total blood protein concentra-
tions.  The calf’s ability to absorb
immunoglobulins is reduced significantly 12
hr after birth.  Therefore, it is critical to
administer colostrum during the first few
hours of life. Total blood protein can be used
to determine if the calf has absorbed suffi-
cient immunoglobulins from the colostrum.
(Key Words: Blood Protein, Colostrum,
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Introduction
Dairy producers have to deal with many
factors related to rearing baby calves.
Colostrum management is one of them.
Many producers attempt to increase the
efficiency of their farm enterprise.  When
time traditionally spent in calf management
is re-allocated to other areas of the farm, calf
health and performance may be impacted
negatively.  However, colostral management,
including quality and timing of the first
feeding of colostrum, is vital. It is well
documented that administering an acceptable
quality and quantity of colostrum within the
first few hours of a calf's life greatly
increases its level of immunity.  Calves with
sufficient colostral intake are less likely to
experience morbidity than calves with insuf-
ficient intake. 
Colostral management on some dairies
includes commingling of first-, second-, and
third-day colostrum into one tank.  Because
first-day colostrum has the highest concen-
trations of immunoglobins, the pooling
practice results in a diluted mixture that may
be inadequate to meet the calf's immunoglob-
ulin requirements.  Colostrum <50 mg/ml
(measured  by  a  co los t rometer )
should not be given to calves during the first
12 hr of life, because the amount of
immunoglobulin is likely to be inadequate.
By measuring total blood protein from
individual calves, producers can
determine accurately the amount of
immunoglobulin absorption (r = 0.88) passed
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from colostrum to the calf, thus, evaluating
the level of passive immunity.  Our objective
was to review recent research concerning the
use of total blood protein as an indicator of
colostral sufficiency and morbidity in dairy
calves.
Review of Research
One method of testing the level of immu-
nity passed to the calf is to measure serum
total protein (TP).  This is done by collecting
blood from a jugular vein of a calf between
1 and 7 days of age.  The blood is centri-
fuged, and the serum is analyzed for TP
using a refractrometer calibrated for this
purpose.  Refractometery provides rapid and
inexpensive results and is useful for monitor-
ing passive immunity status.
Study results have shown that the rela-
tionship between the level of serum TP and
morbidity and mortality of the calf is non-
linear.  One study reported that calves with
TP concentrations >6.5 g/dl had the least
level of risk, whereas calves with TP <5.0
g/dl were 3 to 6 times more likely to experi-
ence health problems, death, or both.  A
much greater reduction in risk was observed
when TP increased from 4.0 g/dl to 5.0 g/dl
than when it increased from 5.5 g/dl to 6.5
g/dl.  The hazard mortality ratio was a con-
stant value from birth to 6 mo.  This ratio
indicates that low concentrations of TP were
associated with high mortality throughout
that entire period.  Data collected from an-
other group show similar results; the lowest
risk for morbidity and mortality was detected
in calves with TP >5.5 g/dl.  Calves with
concentrations of 5.0 g/dl to 5.4 g/dl showed
a very slight increase in the risk of morbidity
and mortality with the highest risk resulting
from TP <4.0 g/dl.  Therefore, we recom-
mend maintaining TP >5.5 g/dl in calves for
decreased risk of subsequent health prob-
lems.
These results cannot predict which calves
will get ill or die and which calves will not.
Some calves with TP >6.0 g/dl will experi-
ence health problems or die, but not at the
rate of calves with lower TP concentrations.
Serum TP is a useful and practical means of
assessing immunoglobulin absorption in the
neonatal calf.  However, one also must pay
special attention to all factors associated with
rearing calves. Following proper herd health
programs is important to help ensure the best
performance.  Herd health programs should
be tailored for the individual dairy and ad-
dress the problems of that dairy.  Solving the
problems of low quality colostrum, as well as
those in the timing and amount of colostrum
administered, will not eliminate neonatal
morbidity and mortality.  However, it is an
essential step in helping to ensure more
adequate, healthy, replacement heifers for
the future. 
